Target intelligence / Profile preview

RNA, U6 small nuclear 833, pseudogene (RNU6-833P)

Target
RNU6-833P
Molecular classification
Other (pseudogene), Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 833, pseudogene (RNU6-833P) is classified as a **pseudogene** of the U6 small nuclear RNA (snRNA) gene family[1]. U6 snRNA is the crucial RNA component of U6 small nuclear ribonucleoprotein, which forms a key part of the spliceosome complex and is essential for catalyzing the removal of introns from pre-mRNA in eukaryotes[5][3]. However, **RNU6-833P itself is a pseudogene**, meaning it is a non-functional genetic element that does not encode an active snRNA molecule. Such pseudogenes are commonly found in the human genome as processed or unprocessed copies of essential RNA genes and typically lack biological activity, although in rare cases, certain pseudogenes have been shown to contribute to disease processes or regulation by acting as decoys for microRNAs or modulating gene expression in a competitive endogenous RNA network[2]. For RNU6-833P in particular, there is no direct evidence of biological function or disease association[1]. This gene does not represent a therapeutic target, nor does it have established roles in canonical cellular processes or as a pharmacological biomarker.

Other names
RNU6-833PRNA, U6 small nuclear 833 pseudogene
02

Biological functions

None established (pseudogenes generally lack biological function, though some pseudogenes in specific contexts can have regulatory or competitive endogenous RNA (ceRNA) effects[2])
03

Disease associations

None directly established for this specific pseudogene; more generally, some pseudogenes may modulate disease mechanisms such as cancer pathways through ceRNA or miRNA sponging activities[2]

Beyond the preview

Go deeper on RNA, U6 small nuclear 833, pseudogene (RNU6-833P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 833, pseudogene (RNU6-833P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call